Stay updated with breaking news from Bcli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Shares of BCLI stock opened at $3.02 on Tuesday. The stock has a market cap of $110.19 million, a P/E […]
Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating) and Molecular Partners (NASDAQ:MOLN – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk. Insider & Institutional Ownership 12.3% of Brainstorm Cell […]
Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating) and MiNK Therapeutics (NASDAQ:INKT – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Profitability This table compares Brainstorm Cell Therapeutics and […]
Equities analysts expect Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Rating) to announce earnings of ($0.13) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Brainstorm Cell Therapeutics’ earnings. Brainstorm Cell Therapeutics posted earnings of ($0.19) per share during the same quarter last year, which would […]
StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, Dawson James reiterated a “neutral” rating on shares of Brainstorm Cell Therapeutics in a report on Wednesday, December 22nd. […]